(Q45150123)

English

Imatinib mesylate may improve fasting blood glucose in diabetic Ph+ chronic myelogenous leukemia patients responsive to treatment

scientific article published in November 2004

Statements

Imatinib mesylate may improve fasting blood glucose in diabetic Ph+ chronic myelogenous leukemia patients responsive to treatment (English)
1 November 2004
4653-4655

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit